Intravenous immunoglobulin preparations as immunomodulatory agents

Area of Science:

• Immunology
• Immunopathology
• Pharmacology

Background:

• Immunopathologic conditions like autoimmune diseases involve altered immune reactions due to dysregulation.
• Antibodies, bifunctional molecules with Fab and Fc portions, are key regulators of immune responses.
• Antibodies can both trigger and suppress immune reactions through various mechanisms.

Purpose of the Study:

• To explore the immunomodulatory potential of exogenous antibodies, specifically intravenous immunoglobulin (IVIG).
• To understand the role of intact IgG molecules in IVIG's therapeutic effects.
• To highlight IVIG as a treatment for chronic inflammatory and autoimmune disorders.

Main Methods:

• Review of antibody structure and function, focusing on Fab and Fc-mediated regulation.
• Examination of evidence for exogenous antibody effects on immune processes.
• Analysis of IVIG's clinical efficacy in autoimmune and inflammatory conditions.

Main Results:

• Antibodies regulate immune responses via Fab (antigen interaction, idiotype/anti-idiotype) and Fc (complement, immune complex clearance, cellular functions) portions.
• Intravenously administered immunoglobulins, particularly high-dose IgG, demonstrate efficacy in managing harmful immune responses.
• IVIG acts as an immunomodulatory agent, requiring intact 7S IgG molecules and adequate plasma concentrations.

Conclusions:

• IVIG is an effective immunomodulatory agent for treating certain autoimmune and chronic inflammatory diseases.
• The therapeutic action of IVIG relies on intact IgG molecules and sustained plasma levels.
• Understanding antibody's dual role in immune regulation informs the use of IVIG in clinical practice.